Longitudinal Analyses of Anti-JCV Antibody Index for Risk Assessment of Progressive Multifocal Leukoencephalopathy

Multiple Sclerosis Journal – Experimental, Translational and Clinical
doi 10.1177/2055217316630008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy

Frontiers in Neurology
Neurology
2020English

Progressive Multifocal Leukoencephalopathy

Journal of Multiple Sclerosis
2013English

Progressive Multifocal Leukoencephalopathy

Neurology
Neurology
2002English

Anti-Jc Virus Antibody Levels in Serum or Plasma Further Define Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

Annals of Neurology
Neurology
2014English

PML Risk Stratification Using Anti-JCV Antibody Index and L-Selectin

Multiple Sclerosis
Neurology
2015English

The Clinical Utility of JC Virus Antibody Index Measurements in the Context of Progressive Multifocal Leukoencephalopathy

Acta Neurologica Scandinavica
MedicineNeurology
2017English

Progressive Multifocal Leukoencephalopathy: Current Insights

Degenerative Neurological and Neuromuscular Disease
2019English

Cerebellar Form of Progressive Multifocal Leukoencephalopathy (PML)

Canadian Journal of Neurological Sciences
MedicineNeurology
1979English

Anti-Jc Virus Antibody Testing for Natalizumab-Induced Progressive Multifocal Leukoencephalopathy: Where Are We and Where Should We Go?

Multiple Sclerosis
Neurology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy